PGHH NSI Week ended 07 Aug 2026

Weekly Investor Report

Procter & Gamble Hygiene and Health Care Limited · Consumer Defensive · Household & Personal Products

Open interactive chart View report data
Latest close 8,497 INR
-1.1% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -15.2% below the Trend Line and sits at 1.2% of its 52-week range. The latest completed week returned -1.1%, after a -5.0% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100.

Setup score 17 out of 100
Latest Close 8,497 INR 7 Aug 2026
1W Return -1.1% latest completed week
4W Return -5.0% short-term follow-through
12W Return -12.5% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 1.2x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -1.1% Latest completed week; four-week move -5.0%. Indicator stack 0/7 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 36.03% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 50/100 31 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -15.2% below the Trend Line and sits at 1.2% of its 52-week range. The latest completed week returned -1.1%, after a -5.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0012-week average 0.01

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.00Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -5.0% over four weeks, -12.5% over 12 weeks, and -34.4% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-1.1%
4W-5.0%
12W-12.5%
26W-28.6%
52W-34.4%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.53Latest activity-pressure read.
Pressure change-422.4%Four-week change in activity pressure.
Leadership-23.93Latest relative-leadership reading.
RS change-13.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 91% Model confidence 85%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength22/100Blend of value, momentum, and quality. Underlying universe rank 79; rank 1 is best.
Value24/100Relative valuation strength. Underlying universe rank 77; rank 1 is best.
Quality94/100Profitability and accounting quality. Underlying universe rank 7; rank 1 is best.
Momentum8/100Medium-term price momentum. Underlying universe rank 93; rank 1 is best.
Growth34/100Revenue and earnings growth. Underlying universe rank 67; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
32.2x
Price divided by trailing earnings.
Price / sales
6.4x
Market value relative to trailing revenue.
EV / EBITDA
22.3x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
3.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
63.4%
Gross profit retained from each unit of revenue.
Operating margin
26.5%
Operating profit retained from revenue.
Free-cash-flow margin
20.4%
Free cash flow generated from revenue.
Return on invested capital
430.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
2.1%
Latest one-year revenue growth.
EPS growth
26.9%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
105.4%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
3.1%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
3.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.5x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 31 relevant articles.

5 positive · 25 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-40.5%Distance below the 52-week high.
13-week volatility2.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher8 of 2618 weeks finished lower.
Best week+6.8%Week of 3 Apr.
Worst week-7.7%Week of 20 Mar.
Latest week-1.1%Week of 7 Aug.

Shape of recent returns

Strong gains1
Modest gains7
Flat weeks0
Modest losses13
Sharp losses5
Recent vol2.3%13-week weekly-return volatility.
Base vol2.7%52-week weekly-return volatility.
Up/down split16/36Count of positive and negative weeks in the 52-week window.
Average skew2.4% / -2.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape14/100

Trend, activity pressure, participation, and risk combine to a 14/100 tape read.

 Indicator analysis18/100

Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.00; No reversal markers Next-Week ExpectancyNegative 36.03%

Next-week expectancy is negative with a 36.03% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors37/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 50 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 31 relevant articles.

Procter & Gamble stock trades steady as margins and cash generation underpin valuation Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20268,497 INR-1.1%10,016 INR13,904 INR-0.53-23.9370.8KOff
31 Jul 20268,594 INR-4.2%10,143 INR13,943 INR-0.39-23.08218.7KOff
24 Jul 20268,974 INR2.9%10,278 INR13,982 INR-0.32-18.2591.7KOff
17 Jul 20268,720 INR-2.5%10,404 INR14,022 INR-0.30-22.8547.5KOff
10 Jul 20268,940 INR0.4%10,531 INR14,062 INR-0.10-21.0253.3KOff
3 Jul 20268,902 INR-1.3%10,652 INR14,099 INR-0.14-22.0313.0KOff
26 Jun 20269,020 INR-2.7%10,768 INR14,132 INR-0.15-20.760Off
19 Jun 20269,274 INR3.1%10,886 INR14,162 INR-0.09-18.8147.3KOff
12 Jun 20268,994 INR-4.3%10,998 INR14,189 INR-0.21-20.4111.4KOff
5 Jun 20269,400 INR-2.6%11,126 INR14,216 INR-0.24-16.415.6KOff
29 May 20269,651 INR0.7%11,244 INR14,241 INR-0.23-15.27109.9KOff
22 May 20269,585 INR-1.2%11,361 INR14,262 INR-0.43-16.8857.9KOff
15 May 20269,706 INR-2.3%11,485 INR14,283 INR-0.48-16.0634.0KOff
8 May 20269,937 INR-2.1%11,613 INR14,303 INR-0.60-16.4553.3KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context